Caisse De Depot Et Placement Du Quebec Bei Gene, Ltd. Transaction History

Caisse De Depot Et Placement Du Quebec

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$125.51 - $229.3 $1.02 Million - $1.86 Million	-8,100 Reduced 46.59%	9,286 $2.04 Million
Q3 2022 Nov 14, 2022	BUY	$131.8 - $202.24 $452,074 - $693,683	3,430 Added 24.58%	17,386 $2.34 Million
Q2 2022 Aug 12, 2022	BUY	$121.11 - $216.05 $1.13 Million - $2.01 Million	9,300 Added 199.74%	13,956 $2.26 Million
Q1 2022 May 13, 2022	SELL	$146.52 - $269.56 $503,149 - $925,669	-3,434 Reduced 42.45%	4,656 $878,000
Q4 2021 Feb 14, 2022	BUY	$248.56 - $389.34 $24,856 - $38,934	100 Added 1.25%	8,090 $2.19 Million
Q3 2021 Nov 12, 2021	BUY	$249.6 - $403.14 $174,720 - $282,198	700 Added 9.6%	7,990 $2.9 Million
Q2 2021 Aug 13, 2021	SELL	$292.75 - $367.01 $58,550 - $73,402	-200 Reduced 2.67%	7,290 $2.5 Million
Q1 2021 May 14, 2021	BUY	$260.64 - $382.12 $16,941 - $24,837	65 Added 0.88%	7,490 $2.61 Million
Q4 2020 Feb 12, 2021	BUY	$221.31 - $316.61 $1.13 Million - $1.62 Million	5,125 Added 222.83%	7,425 $1.92 Million
Q3 2020 Nov 13, 2020	SELL	$189.18 - $286.44 $18,918 - $28,644	-100 Reduced 4.17%	2,300 $659,000
Q2 2020 Aug 14, 2020	SELL	$123.9 - $195.41 $148,680 - $234,492	-1,200 Reduced 33.33%	2,400 $452,000
Q1 2020 May 14, 2020	BUY	$121.84 - $173.19 $134,024 - $190,509	1,100 Added 44.0%	3,600 $443,000
Q4 2019 Feb 14, 2020	BUY	$115.78 - $208.34 $92,624 - $166,672	800 Added 47.06%	2,500 $414,000
Q3 2019 Nov 14, 2019	BUY	$120.61 - $148.29 $205,037 - $252,093	1,700 New	1,700 $208,000

253

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.